IPO registrations (S-1, F-1) · Registrants
Altrazeal Life Sciences Inc.
- SEC CIK
- 1168220 · filings on EDGAR ↗
- Name on the registration
- ULURU Inc.
- Former names
- ULURU INC. (2014–2019); ULURU Inc. (2014–2019); OXFORD VENTURES INC (2002–2006)
- Registration
- Form S-1, first filed 2012-02-14, last 2016-01-29; 4 initial registrations, 2 amendments
- Outcome
- Declared effective 2012-07-31
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- NV
- Business address
- 4410 BELTWAY DRIVE, Addison, TX 75001
- EIN
- 41-2118656
- EDGAR entity type
- operating
- Insiders and CEO pay
- Altrazeal Life Sciences Inc. on the corporate pages
Offering terms
- Shares offered
- 2,500,000
- Listing
- OTCQB under the symbol ULUR
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: ALTRAZEAL LIFE SCIENCES INC. Fuzzy (name and state)
- Form 5500 plan sponsor: ALTRAZEAL LIFE SCIENCES INC. EXACT (EIN (EXACT))
- Federal award recipient: ALTRAZEAL LIFE SCIENCES INC Fuzzy (name and state)
- Form D issuer: Altrazeal Life Sciences Inc. EXACT (CIK (EXACT))
- Lobbying client: ALTRAZEAL LIFE SCIENCES INC. Fuzzy (name and state)
- SEC filer: ULURU Inc. EXACT (CIK (EXACT))
- Person page: Robert F Goldrich Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: William W Crouse Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 11
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2012-02-14 | S-1 | S-1 (registration) | ULURU INC. | 0001168220-12-000007 ↗ |
| 2012-07-24 | S-1/A | S-1/A (amendment) | ULURU INC. | 0001168220-12-000054 ↗ |
| 2012-07-31 | EFFECT | EFFECT (declared effective) | ULURU INC. | 9999999995-12-002332 ↗ |
| 2015-05-13 | S-1 | S-1 (registration) | ULURU Inc. | 0001168220-15-000039 ↗ |
| 2015-05-20 | S-1/A | S-1/A (amendment) | ULURU Inc. | 0001168220-15-000058 ↗ |
| 2015-06-04 | EFFECT | EFFECT (declared effective) | ULURU Inc. | 9999999995-15-001533 ↗ |
| 2015-09-25 | S-1 | S-1 (registration) | ULURU Inc. | 0001168220-15-000097 ↗ |
| 2015-10-09 | EFFECT | EFFECT (declared effective) | ULURU Inc. | 9999999995-15-002697 ↗ |
| 2016-01-29 | S-1 | S-1 (registration) | ULURU Inc. | 0001168220-16-000134 ↗ |
| 2016-02-16 | EFFECT | EFFECT (declared effective) | ULURU Inc. | 9999999995-16-003783 ↗ |
| 2016-04-22 | EFFECT | EFFECT (declared effective) | ULURU Inc. | 9999999995-16-004303 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2016-01-29 | S-1 | registration statement | 2,500,000 | - | OTCQB ULUR | 0 | primary document; shares headline | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| GRAY KERRY P | Director,Officer; Director,Officer,TenPercentOwner | Chief Executive Officer; CHIEF EXECUTIVE OFFICER | 9 | 2006–2014 | |
| Wallberg Terrance K | Director,Officer; Officer | Chief Financial Officer; CHIEF FINANCIAL OFFICER | 11 | 2006–2016 | |
| CROUSE WILLIAM W | Director | 6 | 2006–2010 | person page Fuzzy | |
| JANA PARTNERS LLC | TenPercentOwner | 9 | 2006–2009 | ||
| OSS CAPITAL MANAGEMENT | TenPercentOwner | 7 | 2006–2010 | ||
| BRENCOURT ADVISORS LLC | TenPercentOwner | 5 | 2006–2008 | ||
| Jeffrey B Davis | Director | 8 | 2007–2014 | ||
| Reese David Emery | Director | 5 | 2007 | ||
| Collins William L | TenPercentOwner | 1 | 2007 | ||
| VERNON W ANTHONY | Director | 3 | 2007–2008 | ||
| Van den Hooff Renaat | Officer | Exec Vice President-Operations; President & CEO | 8 | 2007–2010 | |
| AHRENS RONALD A | Director | 2 | 2008 | ||
| Schafer Brother LLC | TenPercentOwner | 2 | 2010 | ||
| SCHAFER OSCAR | TenPercentOwner | 2 | 2010 | ||
| Stone Jeffrey A | Director | 4 | 2010–2013 | ||
| IPMD GmbH | TenPercentOwner | 7 | 2013–2016 | ||
| Kerschbaumer Helmut | Director; Director,TenPercentOwner | 3 | 2013–2014 | ||
| Kuehne Klaus | Director; Director,TenPercentOwner | 3 | 2013–2014 | ||
| Punch Trust | Other | 1 | 2014 | ||
| Sacks Michael Ivan | Other; TenPercentOwnerOther | 3 | 2014–2017 | ||
| Centric Capital Ventures LLC | Other | 3 | 2015–2017 | ||
| Sacks Bradley J. | Director; DirectorOther; Other | 4 | 2015–2017 | ||
| Goldrich Robert F | Director | 1 | 2015 | person page Fuzzy | |
| Shah Vaidehi | Director,Officer | Chief Executive Officer | 3 | 2017 | |
| Bose Arindam | Director | 1 | 2017 | ||
| Shah Anish Vithaldas | Director | 1 | 2017 | ||
| Tiedt Oksana | Director | 1 | 2017 | ||
| Velocitas I LLC | TenPercentOwner | 1 | 2017 | ||
| Velocitas Partners LLC | TenPercentOwner | 2 | 2017 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2023-09-18 | Altrazeal Life Sciences Inc. | Other Health Care | $6,600,000 | $2,216,621 | 2 | 1 |
| 2019-11-25 | ULURU Inc. | Other Health Care | $8,000,000 | $690,000 | 4 | 1 |
| 2017-04-12 | ULURU Inc. | Other Health Care | $5,500,000 | $5,500,000 | 2 | 1 |
| 2016-04-13 | ULURU Inc. | Pharmaceuticals | $1,800,000 | $1,714,000 | 15 | 1 |
| 2015-09-11 | ULURU Inc. | Pharmaceuticals | $1,550,225 | $1,550,225 | 5 | 1 |
| 2015-04-20 | ULURU Inc. | Pharmaceuticals | $500,000 | $500,000 | 1 | 1 |
| 2014-03-14 | ULURU Inc. | Pharmaceuticals | $138,600 | $42,600 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | ALTRAZEAL LIFE SCIENCES INC. | State business registries | name and state | |
| Form 5500 plan sponsor | ALTRAZEAL LIFE SCIENCES INC. | EIN (EXACT) | ||
| Federal award recipient | ALTRAZEAL LIFE SCIENCES INC | Federal spending (USAspending) | name and state | |
| Form D issuer | Altrazeal Life Sciences Inc. | Form D private offerings | CIK (EXACT) | |
| Lobbying client | ALTRAZEAL LIFE SCIENCES INC. | Federal lobbying (LDA) | name and state | |
| Person page | Robert F Goldrich | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | William W Crouse | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| SEC filer | ULURU Inc. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.